AzTrials
AzTrials

CholecystectomyNCT00979186

A Trial to Evaluate Natural Orifice Transgastric Endoscopic Cholecystectomy With Laparoscopic Assistance

A study testing NOTES GEN 1 Toolbox in people with Cholecystectomy, run by Ethicon Endo-Surgery at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The study will document being able to successfully perform transgastric cholecystectomy (laparoscopic visualization) using a small collection of study surgical tools. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cholecystectomy
What is being tested?
NOTES GEN 1 Toolbox
Type of treatment
Medical device
How many people
0 participants
Where
1 siteUnited States
Study dates
Sep 2009to Oct 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Men and women will be enrolled in this study who:
  • Are willing to give consent and comply with evaluation and treatment schedule, able to understand and complete study questionnaires;
  • At least 18 years of age;
  • Have a clinical diagnosis of gallbladder disease indicated for cholecystectomy;
  • ASA Classification I or II (Appendix II); and
  • Have a negative serum pregnancy test (for women of childbearing potential);
  • Have the study procedure attempted.

Who cannot join

  • BMI > 35;
  • Use of immunosuppressive medications (within 6 months of surgery; single burst dosages and inhalable steroids are acceptable);
  • Suspicion of gallbladder cancer, tumor, polyps, or mass;
  • Acute cholecystitis or acute pancreatitis;
  • Presence of common bile duct stones;
  • History of open abdominal surgery;
Show all 18Show fewer
  • Evidence of abdominal abscess or mass;
  • Diffuse peritonitis;
  • Use of anticoagulants or anti-platelet agents (use of daily cardio protective doses of aspirin, up to 81 mg/day, is acceptable and shall not constitute an exclusion criterion) or the presence of coagulopathy;
  • Clinical diagnosis of sepsis;
  • History of peritoneal trauma;
  • Co-morbid condition(s) that could limit the subject's ability to participate in the study or to comply with follow-up requirements, or that could impact the scientific integrity of the trial;
  • Planned concurrent surgical procedure;
  • Prior or planned major surgical procedure within 30 days before or after study procedure;
  • Previous diagnosis of intra-abdominal adhesions;
  • Participation in any other investigational device or drug trial that has not completed the primary endpoint or that clinically interferes with the current study endpoints;
  • Previously enrolled in the current series of 4 trials investigating the EES NOTES GEN1 Toolbox; or
  • Any condition which precludes compliance with the study (Investigator discretion).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Department of Surgery, UCSD

    San Diego, California, 92037

Other trials in United States

About this study

The study will document being able to successfully perform transgastric cholecystectomy (laparoscopic visualization) using a small collection of study surgical tools.

Conditions
Cholecystectomy
Being tested
NOTES GEN 1 Toolbox
Keywords
transgastric cholecystectomy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NOTES GEN 1 ToolboxDevice

    Also called Articulating Hook Knife, Articulating Snare, Articulating Needle Knife, Articulating Graspers, Articulating Biopsy Forceps, Steerable Flex Trocar with Rotary Access Needle,, Flexible Bipolar Hemostasis Forceps, Flexible Maryland Dissector, and Tissue Apposition System.

    Articulating Hook Knife, Articulating Snare, Articulating Needle Knife Articulating Graspers, Articulating Biopsy Forceps, Steerable Flex Trocar with Rotary Access Needle, Flexible Bipolar Hemostasis Forceps, Flexible Maryland Dissector, and Tissue Apposition System.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of procedures completed

    Day of surgery only - study complete at end of prodecure.

    Measured: 1 Day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2009 (estimated)
  2. Study startSep 2009
  3. Primary completionOct 2010
  4. Study completionOct 2010

Why it stopped: Study Terminated - No enrollment, business decision.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00979186
Sponsor's protocol ID
CI-08-0005
Status last verified
Dec 2010
First submitted
16 Sep 2009
Last updated
29 Nov 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing NOTES GEN 1 Toolbox in people with Cholecystectomy, run by Ethicon Endo-Surgery at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 29 Nov 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of procedures completed (time frame: 1 Day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in